中文字幕久区久久中文字幕,五月激情综合中文字幕在线,日韩精品不卡在线观看

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
1 mg	3-5days	￥320.00	登錄后可見(jiàn)	- +
5 mg	3-5days	￥860.00	登錄后可見(jiàn)	- +
10 mg	3-5days	￥1350.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

1 mg

3-5days

￥320.00

登錄后可見(jiàn)

- +

5 mg

3-5days

￥860.00

登錄后可見(jiàn)

- +

10 mg

3-5days

￥1350.00

登錄后可見(jiàn)

- +

基本信息

英文名稱	Elagolix (NBI-56418)
中文名稱	噁拉戈利
CAS號(hào)	834153-87-6
分子式	C32H30F5N3O5
分子量	631.59
外觀	White to off-white powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Elagolix (formerly NBI56418; ABT620; NBI-56418; ABT-620; trade name: Orilissa) is a potent, specific, orally bioavailable, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) used for pain management. It inhibits GnRHR with a Kd of 54 pM. Elagolix was given FDA approval on July 23, 2018, to treat endometriosis-related moderate to severe pain. A short-acting GnRH antagonist, elagolix suppresses ovarian estrogen production in a dose-dependent manner, resulting in partial suppression at lower doses and complete suppression at higher doses. Because Elagolix is non-peptide and readily absorbed through the mouth, it is considered the leader of a new class of GnRH inhibitors known as second-generation inhibitors.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL2564

噁拉戈利

834153-87-6 98+% 3-5days

￥320.00 1 mg

黄片一区二区三区在线观看-亚洲av综合久久国产激情按摩店-欧美日韩国产长车超污-欧美日韩偷拍精品视频

噁拉戈利

Elagolix (NBI-56418)

化學(xué)品安全說(shuō)明書(MSDS)